Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 3/20 | 0.42 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | TACR1 | P25103 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30500657 | 0.83 | SLC1A1 (0.44) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL31103849 | 0.83 | SLC1A1 (0.48) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL14659486 | 0.83 | SLC1A1 (0.44) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL11454462 | 0.82 | CA1 (0.56) | SLC1A1KMT2ACA1CA2CA7 | |
| SCHEMBL3622881 | 0.82 | SLC1A1 (0.43) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL22129783 | 0.82 | SLC1A1 (0.43) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL10351545 | 0.81 | SLC1A1 (0.55) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL11672160 | 0.80 | SLC1A1 (0.45) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL29164157 | 0.79 | SLC1A1 (0.46) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 | |
| SCHEMBL30690363 | 0.79 | SLC1A1 (0.46) | SLC1A1SLC1A3SLC1A2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090227781-A1 | Glycolipid Derivative and Drug Containing the Same as Active Component | JAPAN AS REPRESENTED BY PRESIDENT OF NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY (JP) | 2009-09-10 | — | — | US | disclosed |
| EP-1905766-A1 | GLYCOLIPID DERIVATIVE AND THERAPEUTIC AGENT COMPRISING THE SAME AS ACTIVE INGREDIENT | Japan as represented by President of National Center of Neurology and Psychiatry (JP) | 2008-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090227781-A1 | Glycolipid Derivative and Drug Containing the Same as Active Component | CD4, UGCG, HRH2 | SLC1A1 4263/4885SLC1A3 4308/4885SLC1A2 4324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.